Company BioLineRX Ltd. TEL AVIV STOCK EXCHANGE

Equities

IL0011015182

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Bio Therapeutic Drugs

Inactive Instrument

BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.

ILS in Million	2022	Weight	2023	Weight	Delta
License 96.0 %	-	-	17	96.0 %	-
Oncology and Hematology 4.0 %	0	nan %	1	4.0 %	-

ILS in Million	2022	Weight	2023	Weight	Delta
Israel 100.0 %	0	nan %	18	100.0 %	-

Managers	Title	Age	Since
Philip Serlin CEO	Chief Executive Officer	63	24/09/24
Mali Zeevi DFI	Director of Finance/CFO	48	01/09/01
Irit Gliko-Kabir CTO	Chief Tech/Sci/R&D Officer	-	01/17/01
John Lacey IRC	Investor Relations Contact	-	-
Asaf Aloni PRN	Corporate Officer/Principal	-	-
Tali Yaron Dalah AUD	Comptroller/Controller/Auditor	46	-
Ella Sorani PRN	Corporate Officer/Principal	56	01/17/01
Holly May PRN	Corporate Officer/Principal	-	16/22/16
Tsipi Keren-Lehrer PRN	Corporate Officer/Principal	-	01/19/01

Members of the board	Title	Age	Since
Sandra Panem BRD	Director/Board Member	77	24/14/24
Avraham Molcho BRD	Director/Board Member	66	01/10/01
Aharon Schwartz CHM	Chairman	80	01/04/01
Barbara-Jean Bormann-Kennedy BRD	Director/Board Member	65	19/13/19
Raf Hofstein BRD	Director/Board Member	75	01/03/01
Rami Dar BRD	Director/Board Member	67	01/22/01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,086,589,165	1,086,589,164 ( 100.00 %)	0	100.00 %

Name	Equities	%	Valuation
LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 8.543 %	102,437,055	8.543 %	4 M ILa
Aharon Schwartz 0.3090 %	3,705,000	0.3090 %	150 794 ILa
KSM Mutual Funds Ltd. 0.2251 %	2,699,538	0.2251 %	109 871 ILa
Migdal Mutual Funds Ltd. 0.1137 %	1,363,488	0.1137 %	55 494 ILa
Mali Zeevi 0.0274 %	328,665	0.0274 %	13 377 ILa
Ayalon Mutual Funds Ltd. 0.0174 %	208,216	0.0174 %	8 474 ILa
Philip Serlin 0.0143 %	171,900	0.0143 %	6 996 ILa
Ella Sorani 0.005517 %	66,150	0.005517 %	2 692 ILa
Barbara-Jean Bormann-Kennedy 0.000000 %	0	0.000000 %	- ILa
Holly May 0.000000 %	0	0.000000 %	- ILa

Name	Equities	%	Valuation
Morgan Stanley Capital Services LLC 0.3645 %	291,354	0.3645 %	166 072 ILa
Susquehanna Securities LLC 0.2563 %	204,914	0.2563 %	116 801 ILa
Values First Advisors, Inc. 0.2547 %	203,633	0.2547 %	116 071 ILa
LPL Financial LLC 0.1255 %	100,323	0.1255 %	57 184 ILa
Western International Securities, Inc. 0.1243 %	99,333	0.1243 %	56 620 ILa
PVG Asset Management Corp. 0.0774 %	61,840	0.0774 %	35 249 ILa
RBC Dominion Securities, Inc. 0.0681 %	54,471	0.0681 %	31 048 ILa
Geode Capital Management LLC 0.0500 %	39,993	0.0500 %	22 796 ILa
RATHBONES GROUP PLC 0.0498 %	39,820	0.0498 %	22 697 ILa
Geneos Wealth Management, Inc. 0.0482 %	38,500	0.0482 %	21 945 ILa

BioLineRx Ltd.

Modi'in Technology Park 2 HaMa'ayan Street

7177871, Modi'in

+972 8 642 9100

http://www.biolinerx.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+20.63%	13TCr
REGENERON PHARMACEUTICALS, INC.	+23.21%	12TCr
ARGENX SE	+25.68%	2.77TCr
BIONTECH SE	-20.17%	2.03TCr
GENMAB A/S	-16.82%	1.68TCr
BEIGENE, LTD.	-18.07%	1.56TCr
NEUROCRINE BIOSCIENCES, INC.	+11.92%	1.48TCr
WUXI APPTEC CO., LTD.	-47.70%	1.46TCr
SAREPTA THERAPEUTICS, INC.	+58.32%	1.44TCr

Bio Therapeutic Drugs